Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2013, Article ID 268079, 8 pages
http://dx.doi.org/10.1155/2013/268079
Clinical Study

Circulating Anti-Beta2-Glycoprotein I Antibodies Are Associated with Endothelial Dysfunction, Inflammation, and High Nitrite Plasma Levels in Patients with Intermittent Claudication

Department of Angiology and Vascular Surgery, Getafe University Hospital, Getafe, 28905 Madrid, Spain

Received 4 April 2013; Revised 2 June 2013; Accepted 29 August 2013

Academic Editor: B. L. Slomiany

Copyright © 2013 Cesar Varela et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. J. Maldonado, J. D. H. Miralles, E. M. Aguilar, A. F. Gonzalez, J. R. M. García, and F. A. García, “Relationship between noninvasively measured endothelial function and peripheral arterial disease,” Angiology, vol. 60, no. 6, pp. 725–731, 2009. View at Google Scholar · View at Scopus
  2. L. J. Ignarro, G. Cirino, A. Casini, and C. Napoli, “Nitric oxide as a signaling molecule in the vascular system: an overview,” Journal of Cardiovascular Pharmacology, vol. 34, no. 6, pp. 879–886, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. J. de Haro Miralles, E. Martínez-Aguilar, A. Florez, C. Varela, S. Bleda, and F. Acin, “Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs,” Interactive Cardiovascular and Thoracic Surgery, vol. 9, no. 1, pp. 107–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Marrack, J. Kappler, and B. L. Kotzin, “Autoimmune disease: why and where it occurs,” Nature Medicine, vol. 7, no. 8, pp. 899–905, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. G. K. Hansson and P. Libby, “The immune response in atherosclerosis: a double-edged sword,” Nature Reviews Immunology, vol. 6, no. 7, pp. 508–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Zhou, A. Nicoletti, R. Elhage, and G. K. Hansson, “Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice,” Circulation, vol. 102, no. 24, pp. 2919–2922, 2000. View at Google Scholar · View at Scopus
  7. Q. Xu, R. Kleindienst, W. Waitz, H. Dietrich, and G. Wick, “Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65,” Journal of Clinical Investigation, vol. 91, no. 6, pp. 2693–2702, 1993. View at Google Scholar · View at Scopus
  8. H. Perschinka, B. Wellenzohn, W. Parson et al., “Identification of atherosclerosis-associated conformational heat shock protein 60 epitopes by phage display and structural alignment,” Atherosclerosis, vol. 194, no. 1, pp. 79–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Shoenfeld, R. Gerli, A. Doria et al., “Accelerated atherosclerosis in autoimmune rheumatic diseases,” Circulation, vol. 112, no. 21, pp. 3337–3347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Broder, J. J. Chan, and C. Putterman, “Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases,” Clinical Immunology, vol. 146, no. 3, pp. 197–206, 2013. View at Google Scholar
  11. G. Murdaca, B. M. Colombo, P. Cagnati, R. Gulli, F. Spano, and F. Puppo, “Endothelial dysfunction in rheumatic autoimmune diseases,” Atherosclerosis, vol. 224, no. 2, pp. 309–317, 2012. View at Google Scholar
  12. E. Aslim, T. Hakki Akay, B. Bastürk et al., “The role of antiendothelial cell antibodies in the development and follow-up of coronary and peripheral arterial diseases,” Angiology, vol. 59, no. 2, pp. 209–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Franck, H. L. Staub, J. B. Petracco et al., “Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease,” Angiology, vol. 58, no. 3, pp. 295–302, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Varela, J. de Haro, S. Bleda, L. Esparza, I. L. de Maturana, and F. Acin, “Anti-endothelial cell antibodies are associated with peripheral arterial disease and markers of endothelial dysfunction and inflammation,” Interactive Cardiovascular and Thoracic Surgery, vol. 13, no. 5, pp. 463–467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Schousboe, “β 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway,” Blood, vol. 66, no. 5, pp. 1086–1091, 1985. View at Google Scholar · View at Scopus
  16. J. Nimpf, H. Wurm, and G. M. Kostner, “β2-Glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation,” Atherosclerosis, vol. 63, no. 2-3, pp. 109–114, 1987. View at Google Scholar · View at Scopus
  17. A. Tincani, L. Spatola, E. Prati et al., “The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution,” Journal of Immunology, vol. 157, no. 12, pp. 5732–5738, 1996. View at Google Scholar · View at Scopus
  18. P. L. Meroni, E. Raschi, C. Testoni, and M. O. Borghi, “Endothelial cell activation by antiphospholipid antibodies,” Clinical Immunology, vol. 112, no. 2, pp. 169–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. de Haro, F. Acin, A. Lopez-Quintana et al., “Direct association between C-reactive protein serum levels and endothelial dysfunction in patients with claudication,” European Journal of Vascular and Endovascular Surgery, vol. 35, no. 4, pp. 480–486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Y. Carroll, M. J. Mulla, C. S. Han et al., “Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin,” The American Journal of Reproductive Immunology, vol. 66, no. 4, pp. 286–296, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Stalc, M. Tomsic, M. K. Jezovnik, and P. Poredos, “Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndrome,” Clinical and Experimental Rheumatology, vol. 29, no. 4, pp. 616–623, 2011. View at Google Scholar · View at Scopus
  22. C. Mineo, “Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis,” Current Rheumatology Reports, vol. 15, no. 5, article 324, 2013. View at Google Scholar
  23. P. Kleinbongard, T. Rassaf, A. Dejam, S. Kerber, and M. Kelm, “Griess method for nitrite measurement of aqueous and protein-containing samples,” Methods in Enzymology, vol. 359, pp. 158–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Del Papa, L. Guidali, L. Spatola et al., “Relationship between anti-phospholipid and anti-endothelial cell antibodies III: β2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules,” Clinical and Experimental Rheumatology, vol. 13, no. 2, pp. 179–185, 1995. View at Google Scholar · View at Scopus
  25. P. Kleinbongard, A. Dejam, T. Lauer et al., “Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals,” Free Radical Biology and Medicine, vol. 35, no. 7, pp. 790–796, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ramesh, C. N. Morrell, C. Tarango et al., “Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2,” Journal of Clinical Investigation, vol. 121, no. 1, pp. 120–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. E. Barbato and E. Tzeng, “Nitric oxide and arterial disease,” Journal of Vascular Surgery, vol. 40, no. 1, pp. 187–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. B. R. Clapp, G. M. Hirschfield, C. Storry et al., “Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability,” Circulation, vol. 111, no. 12, pp. 1530–1536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. J. Anderson, “Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction,” Heart Failure Reviews, vol. 8, no. 1, pp. 71–86, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Miyoshi, Y. Li, D. M. Shih et al., “Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice,” Life Sciences, vol. 79, no. 6, pp. 525–531, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Buttari, E. Profumo, A. Capozzi, M. Sorice, and R. Riganò, “Oxidized human beta2-glycoprotein i: its impact on innate immune cells,” Current Molecular Medicine, vol. 11, no. 9, pp. 719–725, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Raschi, C. Testoni, D. Bosisio et al., “Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies,” Blood, vol. 101, no. 9, pp. 3495–3500, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-E. Alard, F. Gaillard, C. Daridon, Y. Shoenfeld, C. Jamin, and P. Youinou, “TLR2 is one of the endothelial receptors for β2-glycoprotein I,” Journal of Immunology, vol. 185, no. 3, pp. 1550–1557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Gladigau, P. Haselmayer, I. Scharrer et al., “A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the antiphospholipid syndrome,” PLoS ONE, vol. 7, no. 7, Article ID e42176, 2012. View at Google Scholar
  36. I. Shapira, D. Andrade, S. L. Allen, and J. E. Salmon, “Brief report: induction of sustained resion in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab,” Arthritis & Rheumatism, vol. 64, no. 8, pp. 2719–2723, 2012. View at Google Scholar
  37. M. Blank, L. Baraam, M. Eisenstein et al., “β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome,” Journal of Autoimmunity, vol. 37, no. 1, pp. 8–17, 2011. View at Publisher · View at Google Scholar · View at Scopus